Dr. Eddrice McMullan praises Accuro for increasing first-attempt success rates and reducing needle passes and placement times, especially in patients with high BMI or scoliosis. “It’s genius,” she says, emphasizing its effectiveness when traditional methods fall short.
Recent Posts
- Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
- RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
- RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
- RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training
- RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
